Literature DB >> 122661

Penicillamine treatment of rheumatoid arthritis with a single daily dose of 250 mg.

I A Jaffe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 122661      PMCID： PMC1543593     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  5 in total

1.  Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.

Authors:  E C Huskisson; T J Gibson; H W Balme; H Berry; H C Burry; R Grahame; F D Hart; D R Henderson; J A Wojtulewski
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

2.  The effect of penicillamine on the laboratory parameters in rheumatoid arthritis.

Authors:  I A Jaffe
Journal:  Arthritis Rheum       Date:  1965-12

3.  Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial.

Authors:  H Berry; S P Liyanage; R A Durance; C G Barnes; L A Berger; S Evans
Journal:  Br Med J       Date:  1976-05-01

4.  Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.

Authors:  A J Dixon; J Davies; T L Dormandy; E B Hamilton; P J Holt; R M Mason; M Thompson; J C Weber; D W Zutshi
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

5.  Penicillamine in rheumatoid disease: a long-term study.

Authors:  A T Day; J R Golding; P N Lee; A D Butterworth
Journal:  Br Med J       Date:  1974-02-02
  5 in total
  2 in total

1.  Maintenance dose of penicillamine in rheumatoid arthritis: a comparison between a standard and a response-related flexible regimen.

Authors:  H F Hill; A G Hill; A T Day; R M Brown; J R Golding; W H Lyle
Journal:  Ann Rheum Dis       Date:  1979-10       Impact factor: 19.103

2.  Age and arthritis.

Authors:  G Holden
Journal:  J R Soc Med       Date:  1982-06       Impact factor: 18.000
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.